Creating Better Malaria Vaccines
Development of Non-Human Primate Models to Assess Immunological Mechanisms and Antigenic Targets of Protective Sporozoite (SPZ) Vaccines and Establish Superior Efficacy of Next Generation SPZ vaccines
This research aims to understand how malaria vaccines work and use that knowledge to create new, more effective vaccines for people.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sanaria, INC. NIH-funded |
| Lab location | 1 site (Rockville, United States) |
| Project ID | NIH-11081642 on NIH RePORTER |
What this research studies
Current malaria vaccines based on sporozoites (SPZ) have shown good results in many clinical trials, but we want to make them even better. This project focuses on understanding how these vaccines protect against malaria and identifying the key parts of the parasite that the immune system targets. By doing this, we hope to develop new ways to test vaccine candidates using laboratory methods and non-human primate models, rather than relying solely on human clinical trials for early stages. This will help us find and develop next-generation malaria vaccines that offer stronger, longer-lasting protection and are more affordable.
Who could benefit from this research
Good fit: This research is relevant to individuals, particularly children, who live in or travel to areas where malaria is common and who could benefit from improved vaccine protection.
Not a fit: Individuals not at risk of malaria infection would not directly benefit from this vaccine development.
Why it matters
Potential benefit: If successful, this work could lead to new malaria vaccines that provide stronger, broader, and more durable protection against the disease, especially for children and adults in affected regions.
How similar studies have performed: Existing sporozoite-based malaria vaccines have already demonstrated excellent safety and effectiveness in numerous clinical trials, indicating a successful foundation for this approach.
Where this research is happening
Rockville, United States
- Sanaria, INC. — Rockville, United States (Active)
Researchers
- Principal investigator: Hoffman, Stephen Lev — Sanaria, INC.
- Study coordinator: Hoffman, Stephen Lev
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.